Medicore Technologies is dedicated to safeguarding patient health through the development of innovative and affordable medical products aimed at the prevention and treatment of sexually transmitted infections (STIs). The company specializes in creating unique urethral-vaginal antiseptic solutions designed to prevent STIs effectively. Medicore’s mission is to ensure that patients have access to safe, effective, and budget-friendly options for infection prevention.

The company adopts a robust research and development strategy focused on creating a range of original antiseptic products that address the pressing public health challenges posed by STIs. This includes enhancing its product portfolio with compounds that exhibit reinforced therapeutic actions while keeping consumers informed about STI risks and preventive measures. Collaborating with esteemed institutions such as N.P. Ogaryov Mordovia State University and Sechenov University, Medicore is committed to advancing its technology across various therapeutic domains. Through these efforts, Medicore Technologies aims to significantly enhance the quality of personal health care for its users.